memantine hydrochloride 10 mg oral tablet

1 INDICATIONS AND USAGE Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. (1)

amneal pharmaceuticals of new york llc

FDA Reported Adverse Reactions
`[1] off label use` `[2] drug ineffective` `[3] diarrhoea` `[4] condition aggravated` `[5] fatigue` `[6] colitis ulcerative` `[7] nausea` `[8] headache` `[9] intentional product use issue` `[10] pyrexia`

3 years ago

OVAL ORANGE IP 173

16 HOW SUPPLIED/STORAGE AND HANDLING

MEMANTINE Hydrochloride Tablets USP, 5 mg, are supplied as orange colored, oblong, biconvex, film-coated tablets debossed “IP 173” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 53746-173-30 Bottles of 60: NDC 53746-173-60 Bottles of 1000: NDC 53746-173-10

MEMANTINE Hydrochloride Tablets USP, 10 mg, are supplied as gray colored, oblong, biconvex, film-coated tablets debossed “IP 174” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 53746-169-30 Bottles of 60: NDC 53746-169-60 Bottles of 1000: NDC 53746-169-10 Store

MEMANTINE Hydrochloride Tablets, USP at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

More pills like OVAL IP 173

Related Pills

Memantine hydrochloride 5 MG Oral Tablet

Amneal Pharmaceuticals of New York LLC

Memantine hydrochloride 10 MG Oral Tablet

amneal pharmaceuticals of new york llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site